Iris Dotan

Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG

Chengyu Liang, Pinghui Feng, Bonsu Ku et al. · Nature Cell Biology · 2006 · 1K citations

Life Sciences, Cell Biology, Molecular Biology +14

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations

Gert Van Assche, Walter Reinisch, C. Janneke van der Woude et al. · Journal of Crohn s and Colitis · 2009 · 897 citations · Full text

Medicine, Clinical Sciences, Surgery +11

Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial

Séverine Vermeire, Sharon O’Byrne, Mary Keir et al. · The Lancet · 2014 · 453 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Cannabis Induces a Clinical Response in Patients With Crohn's Disease: A Prospective Placebo-Controlled Study

Timna Naftali, Lihi Bar‐Lev Schleider, Iris Dotan et al. · Clinical Gastroenterology and Hepatology · 2013 · 321 citations

Medicine, Health Behavior, Gastroenterology +12

Levels of Drug and Antidrug Antibodies Are Associated With Outcome of Interventions After Loss of Response to Infliximab or Adalimumab

Henit Yanai, Lev Lichtenstein, Amit Assa et al. · Clinical Gastroenterology and Hepatology · 2014 · 309 citations

Life Sciences, Immunology, Pharmacology +12